CIP
INFI

Convergence Investment Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Convergence Investment Partners’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-124,904
Closed -$1.75M – 431
2015
Q1 		$1.75M Buy
+124,904
New +$1.91M 0.24% 156

Other funds holding INFI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Convergence Investment Partners's INFI Position: Q2 2015 in Review

Convergence Investment Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2015, closing a stake of 124,904 shares — an estimated $1.75M sold.

Convergence Investment Partners first reported a position in INFI in Q1 2015 and held it in 1 quarter. The position peaked at $1.75M in Q1 2015. 137 funds tracked by Wall St. Rank hold INFI as of Q2 2015.

  • Convergence Investment Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Convergence Investment Partners sold 124,904 Infinity Pharmaceuticals, Inc. shares in Q2 2015, an estimated $1.75M.
  • Convergence Investment Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Convergence Investment Partners's Infinity Pharmaceuticals, Inc. position peaked at $1.75M in Q1 2015.
  • 137 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2015.

Based on Convergence Investment Partners's 13F filing for Q2 2015, filed 5 Aug 2015.